Alnylam Pharmaceuticals, Inc. ALNY
159.85 USD +8.21 (+5.41%)
At closeNov 11, 2026, 4:57 PM EST
160.00 +0.15 +0.09%
After hours · Nov 11, 4:57 PM ET
151.85 Day range 159.91
149.18 52-week range 479.79
- YTD
- -59.80%
- 1 year
- -64.63%
Revenue & Expenses
Revenue by
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 3.71B | 2.25B | 1.83B | 1.04B | 844.29M | |
| 3.71B | 2.25B | 1.83B | 1.04B | 844.29M | |
| 681.87M | 323.37M | 310.41M | 168.82M | 140.14M | |
| 3.03B | 1.92B | 1.52B | 868.60M | 704.14M | |
| 2.53B | 2.10B | 1.80B | 1.65B | 1.41B | |
| 1.32B | 1.13B | 1.00B | 883.01M | 792.16M | |
| 1.21B | 975.53M | 795.65M | 770.66M | 620.64M | |
| 501.58M | -176.88M | -282.18M | -785.07M | -708.65M | |
| 252.63M | 141.86M | 121.22M | 155.97M | 143.02M | |
| 9.40M | -99.22M | 6.72M | 4.16M | 680.00K | |
| 313.75M | -278.16M | -440.24M | -1.13B | -852.82M | |
| 313.75M | -278.16M | -440.24M | -1.13B | -852.82M | |
| 313.75M | -278.16M | -440.24M | -1.13B | -852.82M | |
| 313.75M | -278.16M | -440.24M | -1.13B | -852.82M | |
| 2.39 | -2.18 | -3.52 | -9.30 | -7.20 | |
| 2.39 | -2.18 | -3.52 | -9.30 | -7.20 | |
| 2.33 | -2.18 | -3.52 | -9.30 | -7.20 | |
| 575.78M | -235.52M | -312.30M | -971.02M | -709.12M | |
| 575.78M | -235.52M | -312.30M | -971.02M | -709.12M | |
| 131.00M | 127.65M | 124.91M | 121.69M | 118.45M | |
| 134.68M | 127.65M | 124.91M | 121.69M | 118.45M |